SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
5
#000000
#FFFFFF
Don't Let Trade Trump GMO Labeling
Trade rules have always been one of the biggest hammers the biotech industry has had to push genetically modified crops on the world. Nearly a decade ago, the industry, through its surrogates at the U.S. Trade Representative (USTR), targeted the European Union's precautionary approach to regulating GMO crops at the World Trade Organization and won. Later, Wikileaks revealed numerous cables from U.S.
Oct 02, 2014
Trade rules have always been one of the biggest hammers the biotech industry has had to push genetically modified crops on the world. Nearly a decade ago, the industry, through its surrogates at the U.S. Trade Representative (USTR), targeted the European Union's precautionary approach to regulating GMO crops at the World Trade Organization and won. Later, Wikileaks revealed numerous cables from U.S. embassies in Europe calling for plans to retaliate against countries that didn't support GMO crops.
While working on behalf of the biotech industry internationally, the U.S. government has largely ignored the growing opposition to unlabeled GMOs in the U.S. After the Obama Administration disregarded more than a million comments to the U.S. Food and Drug Administration (FDA) calling for mandatory GMO labeling, advocacy has moved to the state level, where more than 20 US states are considering GMO labeling.
Earlier this year, Vermont was the first state to require GMO labeling without restrictions. The Grocery Manufacturers Association immediately filed a legal challenge to the law. Maine and Connecticut passed GMO labeling laws last year contingent on neighboring states also passing GMO labeling laws. In a few weeks, Colorado and Oregon will vote on ballot initiatives to label GMOs--initiatives Monsanto has poured literally millions into defeating.
But just in case they don't win at the state level, the industry has a back-up plan: Agribusiness companies have been candid that they want the new U.S.-EU trade deal, currently being negotiated, to dismantle GMO labeling policies. Such rules would affect labeling in European countries and U.S. states.
This week, 70 U.S. NGOs from around the country wrote the USTR to demand it not restrict efforts to label GMOs in the ongoing secret U.S.-EU trade talks. The groups also warned against including the very controversial corporate rights provisions (known as investor-state dispute settlement), which grant corporations the right to legally challenge, through secret tribunals, regulations like GMO labeling that could affect future profits.
The secrecy of the US-EU trade negotiations, combined with the insider power of agribusiness and biotech companies, is a potentially toxic combination. IATP will present the letter to negotiators today at a USTR stakeholder meeting and convey the letter's closing sentiment: "We will strenuously oppose any U.S.-EU deal that undermines U.S. consumers' right to know what is in the food they purchase and feed their families."
An Urgent Message From Our Co-Founder
Dear Common Dreams reader, It’s been nearly 30 years since I co-founded Common Dreams with my late wife, Lina Newhouser. We had the radical notion that journalism should serve the public good, not corporate profits. It was clear to us from the outset what it would take to build such a project. No paid advertisements. No corporate sponsors. No millionaire publisher telling us what to think or do. Many people said we wouldn't last a year, but we proved those doubters wrong. Together with a tremendous team of journalists and dedicated staff, we built an independent media outlet free from the constraints of profits and corporate control. Our mission has always been simple: To inform. To inspire. To ignite change for the common good. Building Common Dreams was not easy. Our survival was never guaranteed. When you take on the most powerful forces—Wall Street greed, fossil fuel industry destruction, Big Tech lobbyists, and uber-rich oligarchs who have spent billions upon billions rigging the economy and democracy in their favor—the only bulwark you have is supporters who believe in your work. But here’s the urgent message from me today. It's never been this bad out there. And it's never been this hard to keep us going. At the very moment Common Dreams is most needed, the threats we face are intensifying. We need your support now more than ever. We don't accept corporate advertising and never will. We don't have a paywall because we don't think people should be blocked from critical news based on their ability to pay. Everything we do is funded by the donations of readers like you. When everyone does the little they can afford, we are strong. But if that support retreats or dries up, so do we. Will you donate now to make sure Common Dreams not only survives but thrives? —Craig Brown, Co-founder |
© 2023 Institute for Agriculture and Trade Policy
Ben Lilliston
Ben Lilliston is the Director of Rural Strategies and Climate Change at the Institute for Agriculture and Trade Policy and the co-author of the book "Genetically Engineered Foods: A Self-Defense Guide for Consumers" (2004).
Trade rules have always been one of the biggest hammers the biotech industry has had to push genetically modified crops on the world. Nearly a decade ago, the industry, through its surrogates at the U.S. Trade Representative (USTR), targeted the European Union's precautionary approach to regulating GMO crops at the World Trade Organization and won. Later, Wikileaks revealed numerous cables from U.S. embassies in Europe calling for plans to retaliate against countries that didn't support GMO crops.
While working on behalf of the biotech industry internationally, the U.S. government has largely ignored the growing opposition to unlabeled GMOs in the U.S. After the Obama Administration disregarded more than a million comments to the U.S. Food and Drug Administration (FDA) calling for mandatory GMO labeling, advocacy has moved to the state level, where more than 20 US states are considering GMO labeling.
Earlier this year, Vermont was the first state to require GMO labeling without restrictions. The Grocery Manufacturers Association immediately filed a legal challenge to the law. Maine and Connecticut passed GMO labeling laws last year contingent on neighboring states also passing GMO labeling laws. In a few weeks, Colorado and Oregon will vote on ballot initiatives to label GMOs--initiatives Monsanto has poured literally millions into defeating.
But just in case they don't win at the state level, the industry has a back-up plan: Agribusiness companies have been candid that they want the new U.S.-EU trade deal, currently being negotiated, to dismantle GMO labeling policies. Such rules would affect labeling in European countries and U.S. states.
This week, 70 U.S. NGOs from around the country wrote the USTR to demand it not restrict efforts to label GMOs in the ongoing secret U.S.-EU trade talks. The groups also warned against including the very controversial corporate rights provisions (known as investor-state dispute settlement), which grant corporations the right to legally challenge, through secret tribunals, regulations like GMO labeling that could affect future profits.
The secrecy of the US-EU trade negotiations, combined with the insider power of agribusiness and biotech companies, is a potentially toxic combination. IATP will present the letter to negotiators today at a USTR stakeholder meeting and convey the letter's closing sentiment: "We will strenuously oppose any U.S.-EU deal that undermines U.S. consumers' right to know what is in the food they purchase and feed their families."
Ben Lilliston
Ben Lilliston is the Director of Rural Strategies and Climate Change at the Institute for Agriculture and Trade Policy and the co-author of the book "Genetically Engineered Foods: A Self-Defense Guide for Consumers" (2004).
Trade rules have always been one of the biggest hammers the biotech industry has had to push genetically modified crops on the world. Nearly a decade ago, the industry, through its surrogates at the U.S. Trade Representative (USTR), targeted the European Union's precautionary approach to regulating GMO crops at the World Trade Organization and won. Later, Wikileaks revealed numerous cables from U.S. embassies in Europe calling for plans to retaliate against countries that didn't support GMO crops.
While working on behalf of the biotech industry internationally, the U.S. government has largely ignored the growing opposition to unlabeled GMOs in the U.S. After the Obama Administration disregarded more than a million comments to the U.S. Food and Drug Administration (FDA) calling for mandatory GMO labeling, advocacy has moved to the state level, where more than 20 US states are considering GMO labeling.
Earlier this year, Vermont was the first state to require GMO labeling without restrictions. The Grocery Manufacturers Association immediately filed a legal challenge to the law. Maine and Connecticut passed GMO labeling laws last year contingent on neighboring states also passing GMO labeling laws. In a few weeks, Colorado and Oregon will vote on ballot initiatives to label GMOs--initiatives Monsanto has poured literally millions into defeating.
But just in case they don't win at the state level, the industry has a back-up plan: Agribusiness companies have been candid that they want the new U.S.-EU trade deal, currently being negotiated, to dismantle GMO labeling policies. Such rules would affect labeling in European countries and U.S. states.
This week, 70 U.S. NGOs from around the country wrote the USTR to demand it not restrict efforts to label GMOs in the ongoing secret U.S.-EU trade talks. The groups also warned against including the very controversial corporate rights provisions (known as investor-state dispute settlement), which grant corporations the right to legally challenge, through secret tribunals, regulations like GMO labeling that could affect future profits.
The secrecy of the US-EU trade negotiations, combined with the insider power of agribusiness and biotech companies, is a potentially toxic combination. IATP will present the letter to negotiators today at a USTR stakeholder meeting and convey the letter's closing sentiment: "We will strenuously oppose any U.S.-EU deal that undermines U.S. consumers' right to know what is in the food they purchase and feed their families."
We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.